Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-19 4:08 pm Purchase | 2025-11-14 | 13G | enVVeno Medical Corporation NVNO | Thomas A. Satterfield, Jr. | 1,822,500 9.000% | 1,822,500 (New Position) | Filing History |
| 2025-11-14 4:40 pm Sale | 2025-09-30 | 13G | enVVeno Medical Corporation NVNO | Nantahala Capital Management, LLC | 688,940 3.460% | -596,917 (-46.42%) | Filing History |
| 2025-09-09 12:58 pm Purchase | 2025-09-02 | 13G | enVVeno Medical Corporation NVNO | KINGDON CAPITAL MANAGEMENT L.L.C. | 1,359,261 7.100% | 1,359,261 (New Position) | Filing History |
| 2024-11-14 4:53 pm Sale | 2024-09-30 | 13G | enVVeno Medical Corporation NVNO | Nantahala Capital Management, LLC | 1,285,857 7.056% | -113,731 (-8.13%) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 1,869,219 9.900% | 474,503 (+34.02%) | Filing History |
| 2024-02-23 4:16 pm Unchanged | 2024-02-23 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 1,394,716 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | enVVeno Medical Corporation NVNO | Nantahala Capital Management, LLC | 1,399,588 9.900% | 1,399,588 (New Position) | Filing History |
| 2024-02-14 4:38 pm Purchase | 2023-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 1,394,716 9.900% | 457,201 (+48.77%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 937,515 9.900% | -16,733 (-1.75%) | Filing History |
| 2022-02-14 4:38 pm Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 954,248 9.900% | 954,248 (New Position) | Filing History |
| 2022-02-14 3:28 pm Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | CVI Investments, Inc. | 280,357 2.900% | 280,357 (New Position) | Filing History |
| 2022-02-11 07:39 am Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Mitchell P. Kopin | 431,213 4.400% | 431,213 (New Position) | Filing History |
| 2022-01-19 11:03 am Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Empery Asset Management, LP | 471,579 4.740% | 471,579 (New Position) | Filing History |
| 2021-09-17 5:08 pm Purchase | 2021-09-09 | 13G | Hancock Jaffe Laboratories HJLI | Perceptive Advisors LLC | 954,248 9.900% | 954,248 (New Position) | Filing History |
| 2021-02-19 11:44 am Purchase | 2021-02-09 | 13G | enVVeno Medical Corporation NVNO | CVI Investments, Inc. | 435,714 5.600% | 435,714 (New Position) | Filing History |
| 2021-02-17 10:12 am Purchase | 2021-02-09 | 13G | Hancock Jaffe Laboratories HJLI | Empery Asset Management, LP | 571,428 7.390% | 385,560 (+207.44%) | Filing History |
| 2021-01-29 06:07 am Purchase | 2020-12-31 | 13G | Hancock Jaffe Laboratories HJLI | Mitchell P. Kopin | 191,431 7.000% | 29,614 (+18.30%) | Filing History |
| 2021-01-20 11:08 am Purchase | 2020-12-31 | 13G | Hancock Jaffe Laboratories HJLI | Empery Asset Management, LP | 185,868 4.990% | 185,868 (New Position) | Filing History |